Joint strategy sets direction of EMA and EU medicines regulatory agencies to 2028

EMA and the Heads of Medicines Agencies (HMA) have published their joint EU medicines agencies’ network strategy to 2028 (EMANS), following its recent adoption by the HMA and the…, “I am delighted to present our joint EMA / HMA network strategy to 2028. With new legislation on the horizon, we are preparing for the most significant regulatory reform in…, The six focus areas of the strategy to 2028 build upon those in the EMANS to 2025 with the updated strategy placing more emphasis on the competitiveness of the EU in the…, “With the strategy to 2028, our aim is to ensure a transparent, forward-looking and science-driven roadmap to managing the network's public health priorities. In the face…, The six strategic focus areas of EMANS to 2028The strategic focus areas of the strategy to 2028 are as follows:Accessibility – to facilitate pathways for access to medicines…

Mar 18, 2025 - 12:04

Joint strategy sets direction of EMA and EU medicines regulatory agencies to 2028

EMA and the Heads of Medicines Agencies (HMA) have published their joint EU medicines agencies’ network strategy to 2028 (EMANS), following its recent adoption by the HMA and the…, “I am delighted to present our joint EMA / HMA network strategy to 2028. With new legislation on the horizon, we are preparing for the most significant regulatory reform in…, The six focus areas of the strategy to 2028 build upon those in the EMANS to 2025 with the updated strategy placing more emphasis on the competitiveness of the EU in the…, “With the strategy to 2028, our aim is to ensure a transparent, forward-looking and science-driven roadmap to managing the network's public health priorities. In the face…, The six strategic focus areas of EMANS to 2028The strategic focus areas of the strategy to 2028 are as follows:Accessibility – to facilitate pathways for access to medicines…